Acrivon Therapeutics Inc (ACRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 12-2020 | |
| Operating Expenses | 7,212 | 0 | 2,671 | 0 |
| Operating Income | -7,212 | N/A | -2,671 | N/A |
| Other Income | -8 | 0 | 231 | 0 |
| Pre-tax Income | -7,220 | 0 | -2,440 | 0 |
| Net Income Continuous | -7,220 | N/A | -2,440 | N/A |
| Net Income | $-7,220 | $N/A | $-2,440 | $N/A |
| EPS Basic Total Ops | -4.08 | N/A | -1.38 | N/A |
| EPS Basic Continuous Ops | -4.08 | N/A | -1.38 | N/A |
| EPS Diluted Total Ops | -4.08 | N/A | -1.38 | N/A |
| EPS Diluted Continuous Ops | -4.08 | N/A | -1.38 | N/A |
| EBITDA(a) | $-7,167 | $N/A | $-2,671 | $N/A |